The overall goal of HOPA's education program is to equip oncology pharmacy practitioners with knowledge about current developments and to improve the efficiency of healthcare delivery while maintaining or exceeding the quality of patient care.
In addition to the flagship HOPA Annual Conference, HOPA presents regional conference programming across the country that offer a variety of in-depth clinical education, practice management, and BCOP Recertification offerings.
Welcome to the all-new HOPA Resources where we consider all searches “advanced searches.”
The HOPA Health Policy and Advocacy committee is dedicated to acting as an advocate on behalf of patients as well as representing hematology/oncology pharmacists across the country in legislative and regulatory endeavors.
HOPA is an active and engaged organization that provides crucial education, networking, cutting edge resources and advancement opportunities to our members. Find yourself in HOPA.Join or renew your membership today!
We are pleased to share that research presented at the 2014 HOPA Annual Conference by members Jennifer L Niccolai, PharmD and Danielle L Roman, PharmD, has been published in a recent Journal of Oncology Practice.Read it all here!
Latest Issue of HOPA News now available – read about pharmacy and association events, clinical content, and practice management information.
Submit comments on the Draft ASHP-HOPA Guidelines - Roles and Responsibilities of the Pharmacy Technician in Ambulatory Oncology Pharmacy.
Committee Restructure Orientation – Webinar Recording – This webinar will introduce you to the new HOPA committee structure
Three downloadable flyers you can give to patients to help them understand oncology pharmacy are now available.
Abemaciclib (VERZENIO™, Eli Lilly and Company) in combination with fulvestrant approved for women with HR-positive, HER2-negative...
Pembrolizumab (KEYTRUDA®, Merck & Co., Inc.) approvedfor patients with recurrent locally advanced or metastatic, gastric or...
Nivolumab (OPDIVO, Bristol-Myers Squibb Co.) approved for the treatment of hepatocellular carcinoma (HCC) in patients who have been...
Cabazitaxel (JEVTANA®, Sanofi-Aventis) approved a lower dose of cabazitaxel (20 mg/m2 every 3 weeks) (JEVTANA®, Sanofi-Aventis) in...
Save the date - March 21–24, 2018 - Denver, Colorado.
September 15-16, 2017, at the Chicago Marriott O'Hare. Registration is open.
BCOP Programming: Specialty Sessions & Updates Course
Now pharmacists can fulfill all of their BCOP recertification education with HOPA— the experts in clinical oncology pharmacy. HOPA recently was awarded status as a BCOP recertification credit provider by the Board of Pharmacy Specialties (BPS), and will now provide 38 credits of education per year in a variety of delivery options.
The HOPA BCOP recertification courses address the four Domains of Oncology Pharmacy Specialty Practice and improve your knowledge and problem-solving skills in each area. These courses provide BCOP-specific assessments for practicing clinical oncology pharmacists with a need for specific disease prevention and treatment knowledge and strategies.Learn More
HOPA has created several patient education videos for you to share with your patients and their families.